[
  {
    "ts": null,
    "headline": "5 Stocks With High ROE to Buy as Markets Flatter to Deceive Again",
    "summary": "AA, GL, BBVA, TJX and TEL stand out among the five high-ROE stocks as investors seek resilient plays in volatile markets.",
    "url": "https://finnhub.io/api/news?id=5835e8285544da237fa2d5c6b4ab62a955ce76440fe0807818f3999d38d73fe6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770822240,
      "headline": "5 Stocks With High ROE to Buy as Markets Flatter to Deceive Again",
      "id": 139046383,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GL",
      "source": "Yahoo",
      "summary": "AA, GL, BBVA, TJX and TEL stand out among the five high-ROE stocks as investors seek resilient plays in volatile markets.",
      "url": "https://finnhub.io/api/news?id=5835e8285544da237fa2d5c6b4ab62a955ce76440fe0807818f3999d38d73fe6"
    }
  },
  {
    "ts": null,
    "headline": "Globe Life Stock: Analyst Estimates & Ratings",
    "summary": "Despite Globe Life’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=082e990f12f7a7f6fe15342e6331c3169a8dc2a24f7a84f4722065eb2f44b9c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770812838,
      "headline": "Globe Life Stock: Analyst Estimates & Ratings",
      "id": 139045316,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GL",
      "source": "Yahoo",
      "summary": "Despite Globe Life’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=082e990f12f7a7f6fe15342e6331c3169a8dc2a24f7a84f4722065eb2f44b9c0"
    }
  },
  {
    "ts": null,
    "headline": "5 Insightful Analyst Questions From Globe Life’s Q4 Earnings Call",
    "summary": "Globe Life’s Q4 performance was met with a positive market response, despite revenue and non-GAAP profit coming in slightly below Wall Street expectations. Management attributed the quarter’s growth to strong sales activity in the Medicare Supplement business, higher agent productivity, and continued margin discipline across both life and health segments. In particular, CEO Matt Darden highlighted improvements in technology for lead generation and conversion, as well as favorable mortality trend",
    "url": "https://finnhub.io/api/news?id=4f595bc372e86595a4c5c1f48ef935e45b5be72559c8cb7d3647e9048f34344a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770788411,
      "headline": "5 Insightful Analyst Questions From Globe Life’s Q4 Earnings Call",
      "id": 139041205,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GL",
      "source": "Yahoo",
      "summary": "Globe Life’s Q4 performance was met with a positive market response, despite revenue and non-GAAP profit coming in slightly below Wall Street expectations. Management attributed the quarter’s growth to strong sales activity in the Medicare Supplement business, higher agent productivity, and continued margin discipline across both life and health segments. In particular, CEO Matt Darden highlighted improvements in technology for lead generation and conversion, as well as favorable mortality trend",
      "url": "https://finnhub.io/api/news?id=4f595bc372e86595a4c5c1f48ef935e45b5be72559c8cb7d3647e9048f34344a"
    }
  }
]